• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

US Department of Defense funds MediWound’s non-surgical burn treatment

cafead

Administrator
Staff member
  • cafead   Jan 02, 2024 at 10:12: PM
via Biotherapeutics company MediWound has secured an additional $6.7 million in funding from the US Department of Defense to advance its non-surgical burn treatment for the US Army.

article source